Lexaria Bioscience Corp. (NASDAQ: LEXX) To Intensify Focus On Commercial Execution Of Its Dehydratech Technology For The ...
(MENAFN- Investor Brand Network) 2022 saw Lexaria introduce its patented DehydraTECH(TM) technology to world-leading collaborators while also exploring DehydraTECH-CBD for the potential treatment of hypertension It also saw success in its research for the …